Drug Discovery in Preclinical Research

In the drug development, presymptomatic development, additionally named presymptomatic studies and non-clinical studies, is a stage of investigation that begins before clinical trials (testing in humans) can begin, and during which important feasibility, iterative difficult and drug safety data is collected. Preclinical; in the epidemiological triangle can also be defined as "pre-symptomatic stage" which is known to be, "not yet clinical obvious". 

    Related Conference of Drug Discovery in Preclinical Research

    November 09-11, 2017

    4th European Biopharma Congress

    Vienna, Austria
    August 20-22, 2018

    9th Asian Biologics and Biosimilars Congress

    Tokyo, Japan

    Drug Discovery in Preclinical Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in